• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Bavarian Nordic

182.60 DKK

-0.81 %

Less than 1K followers

BAVA

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.81 %
-3.03 %
+0.58 %
-4.32 %
-3.05 %
-0.68 %
-15.93 %
-33.67 %
+28.02 %

Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S. Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Read more
Market cap
14.47B DKK
Turnover
42.34M DKK
Revenue
6.24B
EBIT %
28.89 %
P/E
10.37
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21.8
2026

Interim report Q2'26

13.11
2026

Interim report Q3'26

Regulatory press release22 hours ago

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic
Regulatory press release22 hours ago

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release6/9/2026, 10:49 AM

Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine

Bavarian Nordic

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release6/9/2026, 10:49 AM

Bavarian Nordic modtager ny ordre fra regering på koppe-/mpoxvacciner

Bavarian Nordic
Regulatory press release6/8/2026, 6:54 AM

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic
Regulatory press release6/8/2026, 6:54 AM

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic
HCA Morgenbørs 03/06 - Overvejende negative markeder og fokus på Genmab og Novo Nordisk
Video6/3/2026, 7:29 AM by
Rasmus Køjborg, Victor Skriver

HCA Morgenbørs 03/06 - Overvejende negative markeder og fokus på Genmab og Novo Nordisk

I dagens Morgenbørs kigger vi ind i overvejende negative markeder, hvor USA-Iran konflikten igen synes at skygge for AI-euforien. Fokus herhjemme på Genmab og Novo Nordisk.

Novo NordiskGenmabDanish Aerospace and Defence CompanyHafniaFLSmidth & Co.BioMar GroupSwiss Properties InvestDSVRockwoolAmbuBavarian Nordic
Regulatory press release6/2/2026, 6:11 AM

Bavarian Nordic lancerer næste del af aktietilbagekøbsprogram

Bavarian Nordic
Regulatory press release6/2/2026, 6:11 AM

Bavarian Nordic Launches Next Tranche of Share Buy-Back Program

Bavarian Nordic
Regulatory press release5/13/2026, 7:01 PM

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Bavarian Nordic
Regulatory press release5/13/2026, 7:01 PM

Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer

Bavarian Nordic
HCA Redflag - Bavarian Nordic (AI)
Analyst Comment5/13/2026, 9:08 AM

HCA Redflag - Bavarian Nordic (AI)

HCA Redflag - Bavarian Nordic (AI)

Bavarian Nordic
HCA Morgenbørs 13/05 - Danske regnskaber i fokus
Video5/13/2026, 7:24 AM by
Rasmus Køjborg, Victor Skriver

HCA Morgenbørs 13/05 - Danske regnskaber i fokus

I dagens Morgenbørs ser vi ind i positive markeder, hvor investorernes fokus er rettet mod dagens møde mellem Donald Trump og Xi Jinping. Herhjemme er der fokus på de regnskabsaktuelle selskaber TORM, NKT, FLSmidth, Bavarian Nordic og Lundbeck.

FLSmidth & Co.NKTGrønlandsbankenLundbeckBavarian NordicNovo Nordisk
Regulatory press release5/13/2026, 5:35 AM

Bavarian Nordic Announces Interim Results for the First Three Months of 2026

Bavarian Nordic
Regulatory press release5/13/2026, 5:35 AM

Bavarian Nordic offentliggør delårsregnskab for første kvartal 2026

Bavarian Nordic
HCA Morgenbørs 12/05 - Negative markeder hvor AI tweet er den skyldige
Video5/12/2026, 7:24 AM by
Rasmus Køjborg, Michael Friis

HCA Morgenbørs 12/05 - Negative markeder hvor AI tweet er den skyldige

I dagens Morgenbørs ser vi ind i negative markeder fra morgenstunden, fredsaftale i respirator og AI tweet den skyldige. Herhjemme fokus Bavarian, Novo, Coloplast, Rockwool og DSV.

Bavarian NordicNovo NordiskColoplastRockwoolDSV
Regulatory press release5/11/2026, 4:30 PM

Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines

Bavarian Nordic
Regulatory press release5/11/2026, 4:30 PM

Bavarian Nordic er blevet tildelt kontraktoptioner af den amerikanske regering til produktion og levering af frysetørret koppevaccine

Bavarian Nordic
Regulatory press release5/11/2026, 7:12 AM

Bavarian Nordic – Completion of Share Buy-Back Program

Bavarian Nordic
Regulatory press release5/11/2026, 7:12 AM

Bavarian Nordic – afslutning af aktietilbagekøbsprogram

Bavarian Nordic